Results 251 to 260 of about 20,867,404 (313)

miRNA‑29a inhibits the proliferation of HUVECs by regulating the ITGB1/β‑catenin/c‑Myc pathway. [PDF]

Mol Med Rep
Sun Q, Chen W, Zhang S, Zhong X, Wu Y, Qian Y, Zhu L, Zhang T, Li W.   +8 more
europepmc   +1 more source

The GFPT2/O-GlcNAcylation/c-Myc axis promotes bladder cancer progression. [PDF]

J Transl Med
Xie H, Liao T, Tang H, Ban C, Cheng Z, Liao K, Li Y, Wei W, Zhou L, Yi X.   +9 more
europepmc   +1 more source

Activation of c-Myc confers resistance to venetoclax via inhibition of Bim in t(8;21)-positive acute myeloid leukemia. [PDF]

Cell Commun Signal
Yin Z, Yao Z, Chen D, Xu D, Xuan L, Liu Q, Ping B, Yu G.   +7 more
europepmc   +1 more source

Moderate downregulation of NDUFA13 promotes cardiomyocytes proliferation and heart regeneration through the glycolysis/c‑Myc/<i>Ccnd1</i> axis. [PDF]

Int J Mol Med
Gao Y, Qian N, Jin J, Liu J, Wang B, Wang Y.   +5 more
europepmc   +1 more source

SerpinB7 promotes c-Myc-mediated glycolysis by interacting with ANXA2 to facilitate the progression of non-small cell lung cancer. [PDF]

Mol Cancer
Zhao F, Zeng F, Zhou P, Zheng H, Hu Y, Tang J, Hu Y, Li G, Feng Y, Wang X, Yu J, Li Y, Yue C, Liu X, Zhang T, Huang N, Sun X, Wang X, Huang S, He M, Zeng X, Wu W, Cui X, Cui K, Li J.   +24 more
europepmc   +1 more source

CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability. [PDF]

J Transl Med
He C, Tang C, Guo J, Yin X, Zhu Q, Fang C.   +5 more
europepmc   +1 more source

Correction to: “Delivery of Pleckstrin‐Homology Domains Suppresses PI3K/Akt Signaling and Breast Cancer Metastasis”

Advanced Science, EarlyView.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epigenetic Modifications of c-MYC: Role in Cancer Cell Reprogramming, Progression and Chemoresistance.

Seminars in Cancer Biology, 2020
Both genetic and epigenetic mechanisms intimately regulate cancer development and chemoresistance. Different genetic alterations are observed in multiple genes, and most are irreversible.
Homa Fatma, S. Maurya, Hifzur R Siddique
semanticscholar   +1 more source

c-Myc-driven Hepatocarcinogenesis

Anticancer Research, 2021
Dysregulation of the c-Myc gene is frequently found in human hepatocellular carcinoma (HCC), often accompanied by genetic and epigenetic alterations in other cancer-related genes. Here, we investigated the tumorigenic potential of c-Myc in diverse genetic environments in which the Ras, Wnt/β-catenin, Sonic hedgehog, or P53 pathways were either ...
Hyuk, Moon, Hyunjung, Park, Simon Weonsang, Ro   +2 more
openaire   +2 more sources

Recent Update on Targeting c-MYC G-Quadruplexes by Small Molecules for Anticancer Therapeutics.

Journal of Medicinal Chemistry, 2020
Guanine-rich DNA sequences have the propensity to adopt four-stranded tetrahelical G-quadruplex (G4) structures that are overrepresented in gene promoters. The structural polymorphism and physicochemical properties of these non-Watson-Crick G4 structures
Ritapa Chaudhuri, Semantee Bhattacharya, Jyotirmayee Dash, S. Bhattacharya   +3 more
semanticscholar   +1 more source